Sign in

    Simran Kaur

    Research Analyst at Wells Fargo & Company

    Simran Kaur is an Equity Analyst at Wells Fargo Securities LLC, where she specializes in equity research with a focus on financial and industrial sectors. Prior to joining Wells Fargo, she worked as an Associate at Piper Sandler & Co., gaining experience in brokerage and investment banking services targeted to institutional clients. With a background across multiple brokerage divisions, Kaur provides targeted research and analysis to support investment decisions for both corporate and institutional investors. She holds professional credentials pertinent to her roles in equities analysis, further establishing her expertise in the finance industry.

    Simran Kaur's questions to Hyperfine (HYPR) leadership

    Simran Kaur's questions to Hyperfine (HYPR) leadership • Q2 2025

    Question

    Simran Kaur of Wells Fargo inquired about the drivers for the high and low ends of the 2025 revenue guidance, the cadence of the next-gen SWOOP system launch, and the commercial traction seen in the neurology office setting.

    Answer

    CFO Brett Hale clarified that Q3 revenue growth is expected to be 50% greater than the dollar increase from Q1 to Q2. CEO Maria Sainz added that confidence in the second-half ramp comes from multiple new revenue layers, including the accelerated US hospital business with the new system, the full launch into the office setting, and international expansion. Sainz noted the primary focus is on new system sales at a higher ASP, with potential for market segmentation. She also highlighted the success of the office pilot program and the rapid enrollment in the NeuroPMR study, which validates the strong clinical enthusiasm.

    Ask Fintool Equity Research AI

    Simran Kaur's questions to RxSight (RXST) leadership

    Simran Kaur's questions to RxSight (RXST) leadership • Q2 2025

    Question

    Simran Kaur of Wells Fargo inquired about business trends exiting Q2 and into Q3 2025, referencing prior commentary on a lack of volume acceleration in June, and asked if analyst models for Q3 are now properly calibrated.

    Answer

    CFO Shelley Thunen stated that while it is still early in Q3, the company is mindful of the trends from Q2 and typical third-quarter seasonality. Thunen confirmed that consensus estimates are currently in the middle of the full-year revenue guidance of $120 million to $130 million and reiterated that H2 revenue is expected to be significantly lower than H1.

    Ask Fintool Equity Research AI

    Simran Kaur's questions to INSULET (PODD) leadership

    Simran Kaur's questions to INSULET (PODD) leadership • Q2 2025

    Question

    Simran Kaur, on for Larry Biegelsen, asked for clarity on the implied Q4 U.S. growth range, questioning what factors would lead to the high versus low end, and sought perspective on whether 20% is a sustainable growth rate for the U.S. business into 2026.

    Answer

    EVP & CFO Ana Maria Chadwick clarified that underlying business trends remain very stable. She explained that after normalizing for prior-year stocking and current-quarter rebate timing, the U.S. business grew 24% in the first half. She stated the back-half guidance is strong in that context and that the company's momentum is expected to continue.

    Ask Fintool Equity Research AI

    Simran Kaur's questions to INSULET (PODD) leadership • Q2 2025

    Question

    Simran Kaur from Wells Fargo questioned the wide implied Q4 growth range for the U.S. business and asked whether 20% growth remains a reasonable expectation for the U.S. segment going forward.

    Answer

    EVP & CFO Ana Maria Chadwick clarified that underlying business trends are very stable. She explained that after normalizing for prior-year stocking and current-year rebate timing, the U.S. business grew 24% in the first half. In this context, she described the back-half guidance as very strong and expressed confidence in continued momentum, deferring comments on 2026.

    Ask Fintool Equity Research AI